SCHEMBL8355178

SCHEMBL8355178

COc1ccc(-c2csc(NS(=O)(=O)c3ccc(C)cc3)n2)cc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KDM1A O60341 5/20 0.80
MAOA P21397 4/20 0.80
MEN1 O00255 6/20 0.76
KMT2A Q03164 6/20 0.76
MAPT P10636 4/20 0.76
LMNA P02545 2/20 0.76
NPSR1 Q6W5P4 1/20 0.74
KDM4E B2RXH2 2/20 0.68
HTT P42858 2/20 0.68
SMN1; SMN2 Q16637 2/20 0.68
NPC1 O15118 1/20 0.68
ALDH1A1 P00352 1/20 0.68
POLB P06746 1/20 0.68
MAPK1 P28482 1/20 0.68
RECQL P46063 1/20 0.68
KCNQ1 P51787 1/20 0.67
PTGS2 P35354 1/20 0.64
GAA P10253 1/20 0.62
GFER P55789 1/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8355128 0.91 KDM1A (0.87) KDM1AMAOAMEN1KMT2AMAPT
SCHEMBL2763474 0.89 KDM1A (0.79) KDM1AMAOAMEN1KMT2AMAPT
SCHEMBL2762943 0.85 KDM1A (0.72) KDM1AMAOAMEN1KMT2AMAPT
SCHEMBL8356809 0.85 KDM1A (1.00) KDM1AMAOAMEN1KMT2ANPSR1
SCHEMBL8355657 0.85 KDM1A (0.77) KDM1AMAOAMEN1KMT2AMAPT
SCHEMBL728209 0.85 KDM1A (0.72) KDM1AMAOAMEN1KMT2AMAPT
SCHEMBL8360649 0.85 KDM1A (0.66) KDM1AMAOAMEN1KMT2AMAPT
SCHEMBL15113217 0.84 MAPT (0.74) KDM1AMAOAMEN1KMT2AMAPT
SCHEMBL8356715 0.84 MEN1 (0.66) KDM1AMAOAMEN1KMT2AMAPT
SCHEMBL8355112 0.82 MEN1 (0.72) KDM1AMAOAMEN1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5877193-A NERVOUS SYSTEM DISORDERS; PSYCHOLOGICAL DISORDERS HOFFMANN-LA ROCHE INC. (US) 1999-03-02 US claimed
US-5958910-A Use of N-(4-aryl-thiazol-2-yl)-sulfonamides HOFFMANN-LA ROCHE INC. (US) 1999-09-28 US disclosed
US-5877193-A NERVOUS SYSTEM DISORDERS; PSYCHOLOGICAL DISORDERS HOFFMANN-LA ROCHE INC. (US) 1999-03-02 US disclosed
EP-0819681-A2 N-(4-Aryl-thiazol-2-yl)-sulfonamides and their use F. HOFFMANN-LA ROCHE AG (CH) 1998-01-21 EP disclosed